加科思药业集团有限公司（股票代码：01167）于2026年3月23日公告称，公司当日于香港联交所场内回购普通股80,100股，占已发行股本约0.01019%。每股回购价介乎6.22港元至6.28港元，总金额为499,779港元。
回购完成后，公司最新的已发行股本数量为786,039,480股，库藏股增至5,715,600股。公司回购授权于2025年6月10日通过，剩余可回购股份数量为78,873,528股。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。
本公告由公司董事王晓洁签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.